1van der Linden IJ, Afman LA, Heil SG, et al. (2006) Genetic variation in genes of folate metabolism and neural-tube defect risk. Proc Nutr Soc 65, 204–215.
2MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338, 131–137.
3Berry RJ, Li Z, Erickson JD, et al. (1999) Prevention of neural-tube defects with folic acid in China. N Engl J Med 341, 1485–1490.
4Buttriss J (2005) Strategies designed to increase awareness about folates and health and to increase folate intake: a review. Trends Food Sci Technol 16, 246–252.
5Czeisel AE & Kökény M (2002) Bread is fortified with folic acid in Hungary. Br Med J 325, 391.
6Bower C, Miller M, Payne J, et al. (2005) Promotion of folate for the prevention of neural tube defects: who benefits? Paediatr Perinat Epidemiol 19, 435–444.
7Finglas PM, de Meer K, Molloy A, et al. (2006) Research goals for folate and related B vitamin in Europe. Eur J Clin Nutr 60, 287–294.
8Food Safety Authority of Ireland (2006) Report of the National Committee on Folic Acid Food Fortification. Dublin: FSAI.
9Krawinkel M, Brönstrup A, Bechthold A, et al. (2006) Strategien zur Verbesserung der Folatver-sorgung in Deutschland – Nutzen und Risiken. Ernaehrungs-Umschau 53, 468–479.
10SACN (2006) Folate and Disease Prevention. London: The Stationery Office.
13Botto LD, Lisi A, Bower C, et al. (2006) Trends of selected malformations in relation to folic acid recommendations and fortification: an international assessment. Birth Defects Res A Clin Mol Teratol 76, 693–705.
14Cornel MC, de Smit DJ & de Jong-van den Berg LTW (2005) Folic acid – the scientific base for a public health policy. Reprod Toxicol 20, 411–415.
15Chen CP (2008) Syndromes, disorders and maternal risk factors associated with neural tube defects (IV). Taiwan J Obstet Gynecol 47, 141–150.
16Mitchell LE (2005) Epidemiology of neural tube defects. Am J Med Genet C Semin Med Genet 135C, 88–94.
17Mills JL & Signore C (2004) Neural tube defect rates before and after food fortification with folic acid. Birth Defects Res 70, 844–845.
18Joò JG, Beke A, Papp Z, et al. (2007) Risk of recurrence in major central nervous system malformations between 1976 and 2005. Prenat Diag 27, 1028–1032.
19Grosse SD & Collins JS (2007) Folic acid supplementation and neural tube defect recurrence prevention. Birth Defects Res A Clin Mol Teratol 79, 737–742.
20Queisser-Luft A, Stolz G, Wiesel A, et al. (2002) Malformations in newborn: results based on 30 940 infants and fetuses from Mainz congenital birth defect monitoring system (1990–1998). Arch Gynecol Obstet 266, 163–167.
21ICMR, Central Technical Co-ordinating Unit (2000) Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian J Med Res 112, 206–211.
22Rothenberg SP, da Costa MP, Sequeira JM, et al. (2004) Autoantibodies against folate receptors in women with a pregnancy complicated by a neural-tube defect. N Engl J Med 350, 134–142.
23López-Camelo JS, Orioli IM, da Graça Dutra M, et al. (2005) Reduction of birth prevalence rates of neural tube defects after folic acid fortification in Chile. Am J Med Genet 135A, 120–125.
24CDC (2004) Spina bifida and anencephaly before and after folic acid mandate – United States, 1995–1996 and 1999–2000. MMWR Morb Mortal Wkly Rep 53, 362–365.
25Williams LJ, Rasmussen SA, Flores A, et al. (2005) Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995–2002. Pediatrics 116, 580–586.
26De Wals P, Tairou F, Van Allen MI, et al. (2007) Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med 357, 135–142.
27Gucciardi E, Pietrusiak MA, Reynolds DL, et al. (2002) Incidence of neural tube defects in Ontario, 1986–1999. CMAJ 167, 237–240.
28Moore LL, Bradlee ML, Singer MR, et al. (2003) Folate intake and the risk of neural tube defects: an estimation of dose-response. Epidemiology 14, 200–205.
29Czeizel AE, Dobó M & Vargha P (2004) Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Birth Defects Res A Clin Mol Teratol 70, 853–861.
30Klusmann A, Heinrich B, Stoepler H, et al. (2005) A decreasing rate of neural tube defects following the recommendations for periconceptional folic acid supplementation. Acta Paeditrica 94, 1538–1542.
31CDC (2008) Prevalence of neural tube defects and folic acid knowledge and consumption – Puerto Rico, 1996–2006. MMWR Morb Mortal Wkly Rep 57, 10–13.
32Busby A, Armstrong B, Dolk H, et al. (2005) Preventing neural tube defects in Europe: a missed opportunity. Reprod Toxicol 20, 393–402.
33Queisser-Luft A & Spranger J (2006) Congenital malformations. Dtsch Aertzebl 103, 2462–2471.
34FDA (1993) Food labeling: health claims and labeling statements: folate and neural tube defects. Fed Regist 58, 53254–53295.
35Yang QH, Carter HK, Mulinare J, et al. (2007) Race–ethnicity differences in folic acid intake in women of childbearing age in the United States after folic acid fortification: findings from the National Health and Nutrition Examination Survey, 2001–2002. Am J Clin Nutr 85, 1409–1416.
36Choumenkovitch SF, Selhub J, Wilson PW, et al. (2002) Folic acid intake from fortification in United States exceeds predictions. J Nutr 132, 2792–2798.
37Pfeiffer CM, Caudill SP, Gunter EW, et al. (2005) Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999–2000. Am J Clin Nutr 82, 442–450.
38Dietrich M, Brown CJP & Block G (2005) The effect of folate fortification of cereal-grain products on blood folate status, dietary folate intake, and dietary folate sources among adult non-supplement users in the United States. J Am Coll Nutr 24, 266–274.
39CDC (2007) Folate status in women of childbearing age, by race/ethnicity – United States, 1999–2000, 2001–2002, and 2003–2004. MMWR Morb Mortal Wkly Rep 55, 1377–1380.
40Pfeiffer CM, Johnson CL, Jain RB, et al. (2007) Trends in blood folate and vitamin B12 concentrations in the United States, 1988–2004. Am J Clin Nutr 86, 718–727.
41Esfahani ST, Cogger EA & Caudill MA (2003) Heterogeneity in the prevalence of methylenetetrahydrofolate reductase gene polymorphisms in women of different ethnic groups. J Am Diet Assoc 103, 200–207.
42Oakley GP (2007) When will we eliminate folic acid-preventable spina bifida? Epidemiology 18, 367–368.
43Johnston RB (2008) Will increasing folic acid in fortified grain products further reduce neural tube defects without causing harm? Consideration of the evidence. Pediatr Res 63, 1–3.
44Quinlivan EP & Gregory JF (2007) Reassessing folic acid consumption patterns in the United States (1999–2004): potential effect on neural tube defects and overexposure to folate. Am J Clin Nutr 86, 1773–1779.
45Botto LD, Lisi A, Robert-Gnansia E, et al. (2005) International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ 330, 571.
46Charles DH, Ness AR, Campbell D, et al. (2005) Folic acid supplements in pregnancy and birth outcome: re-analysis of a large randomised controlled trial and update of Cochrane review. Paediatr Perinat Epidemiol 19, 112–124.
47Canfield MA, Collins JS, Botto LD, et al. (2005) Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study. Birth Defects Res A Clin Mol Teratol 73, 679–689.
48Johnson CY & Little J (2008) Folate intake, markers of folate status and oral clefts: is the evidence converging? Int J Epidemiol 26, 1–18.
49Lawrence M & Riddell L (2007) Mandatory fortification with folic acid – what would Hippocrates say? Aust Fam Physician 36, 69–73.
50Smith AD (2007) Folic acid fortification: the good, the bad, and the puzzle of vitamin B12. Am J Clin Nutr 85, 3–5.
51Smith AD, Young-In K & Refsum H (2008) Is folic acid good for everyone? Am J Clin Nutr 87, 517–533.
52Ulrich CM & Potter JD (2007) Folate and cancer – timing is everything. JAMA 297, 2408–2409.
53Mason JB, Dickstein A, Jacques PF, et al. (2007) A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev 16, 1325–1329.
54Morris MS, Jacques PF, Rosenberg IH, et al. (2007) Folate and vitamin B12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 87, 193–200.
55Selhub J, Morris MS & Jacques PF (2007) In vitamin B12 deficiency, higher serum folate is associated with increased total homocysteine and methylmalonic acid concenrations. PNAS 104, 19995–20000.
56Bazzano LA, Reynolds K, Holder KN, et al. (2006) Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA 296, 2720–2726.
57Winkels RM, Brouwer IA, Clarke R, et al. (2008) Bread cofortified with folic acid and vitamin B-12 improves the folate and vitamin B-12 status of healthy older people: a randomized controlled trial. Am J Clin Nutr 88, 348–355.